etanidazole has been researched along with Carcinoma, Anaplastic in 7 studies
Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, R | 1 |
| Apte, S | 1 |
| Vilalta, M | 1 |
| Subbarayan, M | 1 |
| Miao, Z | 1 |
| Chin, FT | 1 |
| Graves, EE | 1 |
| Dragowska, WH | 1 |
| Warburton, C | 1 |
| Yapp, DT | 1 |
| Minchinton, AI | 1 |
| Hu, Y | 1 |
| Waterhouse, DN | 1 |
| Gelmon, K | 1 |
| Skov, K | 1 |
| Woo, J | 1 |
| Masin, D | 1 |
| Huxham, LA | 1 |
| Kyle, AH | 1 |
| Bally, MB | 1 |
| Brown, JM | 1 |
| Yu, NY | 1 |
| Brown, DM | 1 |
| Lee, WW | 1 |
| Waleh, NS | 1 |
| Brody, MD | 1 |
| Knapp, MA | 1 |
| Mendonca, HL | 1 |
| Lord, EM | 1 |
| Koch, CJ | 1 |
| Laderoute, KR | 1 |
| Sutherland, RM | 1 |
| Teicher, BA | 1 |
| Holden, SA | 1 |
| Goff, DA | 1 |
| Wright, JE | 1 |
| Tretyakov, O | 1 |
| Ayash, LJ | 1 |
| Lee, DJ | 1 |
| Moini, M | 1 |
| Giuliano, J | 1 |
| Westra, WH | 1 |
| Cox, JD | 1 |
1 review available for etanidazole and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Hypoxic sensitizer and cytotoxin for head and neck cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Hypoxia; Clinical Trials as Topic; Clinical Trials, | 1996 |
6 other studies available for etanidazole and Carcinoma, Anaplastic
| Article | Year |
|---|---|
18F-EF5 PET Is Predictive of Response to Fractionated Radiotherapy in Preclinical Tumor Models.
Topics: Adenocarcinoma; Animals; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Dose Fractionation, Radiation; E | 2015 |
HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.
Topics: Adaptation, Physiological; Animals; Biomarkers; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cell Line | 2004 |
SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
Topics: Animals; Carcinoma; Cell Line; Central Nervous System; Cricetinae; Dogs; Etanidazole; Female; In Vit | 1981 |
Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker.
Topics: Carcinoma; Colonic Neoplasms; Endothelial Growth Factors; Etanidazole; Gene Expression Regulation, N | 1995 |
Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide +/- hepatic enzyme effectors.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Pro | 1996 |
Clinical science and patient care: lessons from cooperative randomized clinical trials.
Topics: Carcinoma; Cell Hypoxia; Etanidazole; Head and Neck Neoplasms; Humans; Multicenter Studies as Topic; | 1997 |